6 Literaturverzeichnis

6 Literaturverzeichnis

Adam, A., Lederer, E., Muramyl peptides: Immunomodulators, sleep factors and vitamins. Med. Res. Rev. 4, 111-153, 1984.

Akao, T., Correlation between physicochemical characteristics of synthetic cationic am- phiphiles and their DNA transfection ability. Bull. Chem. Soc. Jpn. 64, 3677-3681, 1991.

Allison, A.C., Byars, N.E., Immunological adjuvants: desirable properties and side-effects. Mol. Immunol. 28, 279-284, 1991.

Alving, C.R., Verma, J.N., Rao, U., Krzych, U., Amselem, S. Green, S.M., Wassef, N.M., Liposomes containing lipid A as potent non-toxic adjuvant. Res. Immunol. 143, 197-198, 1992.

Alving, C.R., Lipopolysaccharide, lipid A and liposomes containing lipid A as immuno- logic adjuvants. Immunobiology 187, 430-446, 1993.

Anderson, W.F., Human gene therapy. Nature 392, 25-30, 1998.

Aprile, M.A., Wardlaw, A.C.,Aluminum compounds as adjuvants for vaccines and toxoids in man: a review. Can. J. Publ. Hlth 57, 343-354, 1966.

Avrameas, S., Guilbert, B., Dosage enzymoimmunologique de protéine à l'aide d'immu- noadsorbants et d'antigènes marqués aux enzymes. C. R. Acad. Sci.(Paris) 273, 2705-2707, 1971.

Bally, M.B., Harvie, P., Wong, F.M.P., Kong, S., Wasan, E.K., Reimer, D.L., Biological barriers to cellular delivery of lipid-based DNA carriers. Adv. Drug Deliv. Rev. 38, 291- 315, 1999.

Behr, J.P., Gene transfer with synthetic cationic amphiphiles: Prospects for Gene Therapy. Bioconj. Chem. 5, 382-389, 1994.

Binnig, G., Quate, C.F., Gerber, C., Atomic force microscopy. Phys. Rev. Lett. 56, 930- 933, 1986.

Biocompare.com, Auflistung kommerzieller liposomaler Transfektiosagenzien unter http://biocompare.com

Birchall, J.C., Kellaway, I.W., Mills, S.N., Physico-chemical characterisation and trans- fection efficiency of lipid-based gene delivery complexes. Int. J. Pharm. 183, 195-207, 1999.

Blennow, M., Granstrom, M., Strandell, A., adverse reactions after diphtheria-tetanus booster in 10-year-old school childern in relation to the type of vaccine given for the pri- mary vaccination. Vaccine 12, 427-430, 1994. 175 6 Literaturverzeichnis

Boltri, L., Canal, T., Esposito, P., Carli, F., Relevant factors affecting the formulation and growth of lipid nanospheres suspensions. Eur. J. Pharm. Biopharm. 41, 70-75, 1995.

Borchard, G., Chitosans for gene delivery. Adv. Drug Del. Rev. 52(2), 145-150, 2001.

Boussif, O., Lezoualc´h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B., Behr, J.-P., A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297-7301, 1995.

Briones, M., Singh, M., Ugozzoli, M., Karzzaz, J., Klakamp, S., Ott, G., O’Hagan, D., The preparation, characterization and evaluation of cationic microparticles for DNA vaccine delivery. Pharm. Res. 18(5), 709-712, 2001.

Brown, M.D., Schätzlein, A.G., Uchegbu, I.F., Gene delivery with synthetic (non viral) carriers. Int. J. Pharm. 229, 1-21, 2001.

Bunjes, H., Siekmann, B., Westensen, K., Emulsions of supercooled melts – a novel drug delivery system. In: Benita, S. (Ed.), Submicron emulsions in drug targeting and delivery. Harwood academic publishers, 175-204, 1998.

Burger, A., Wachter, H., Hunnius Pharmazeutisches Wörterbuch. Walter de Gruyter Ber- lin, 7.Auflage, 1993.

Capecchi, M.R., High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22, 479-488, 1980.

Cartier, R., Reszka, R., Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther. 9, 157-167, 2002.

Chang, J.C., Diveley, J.P., Savary, J.R., Jensen, F.C., Adjuvant activity of incomplete Freund´s adjuvant. Adv. Drug Del. Rev. 32, 173-186, 1998.

Chesnoy, S., Huang, L., Structure and function of lipid-DNA complexes for gene delivery. Ann. Rev. Biophys. Biomol. Struct. 29, 27-47, 2000.

Chesnoy, S., Durand, D., Doucet, J., Stolz, D.B., Huang, L., Improved DNA/Emulsion complex stabilized by poly(ethylene glycol) conjugated phospholipids. Pharm. Res. 18, 1480-1484, 2001.

Christ, M., Lusky, M., Stoeckel, F., Deryer, D, Dieterle, A., Michou, A.I., Pavirani, A., Mehtali, M., Gene therapy with recombinant adenoviruy vectors: evaluation of the host immune response. Immunol. Lett. 57(1-3), 19-25, 1997.

Chung, H., Kim, T.W., Kwon, M., Kwon, I.C., Jeong, S.Y., Oil components modulate physical characteristics and functionn of the natural oil emulsions as drug or gene delivery system. J. Contr. Rel. 71(3), 339-350, 2001.

Ciftci, K., Levy, R.J., Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. Int. J. Pharm. 218, 81-92, 2001.

Cleland, J.L., Barron, L., Berman, P.W., Daugherty, A., Gregory, T., Lim, A., Vennari, J., Wrin, T., Powell, M.F., Development of a single-shot subunit vacine for HIV-1. Part 2.

176 6 Literaturverzeichnis

Defining optimal autoboost characteristics to maximize the humoral immune response. J. Pharm. Sci. 60, 2289-2295, 1996.

Collier, L.H., Polakoff, S., Mortimer, J., Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines. Lancet 1, 1364-1368, 1979.

Cotton, M., Wagner, E., Zatloukal, K., Philips, S., Currel, D.T., Birnstile, M.L., High- efficiancy receptor mediated delivery of small and large (48 kb) gene constructs using the endosome disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. USA 89, 6094-6098, 1992.

Cox, J.C., Coulter, A.R., Adjuvants - a classification and review of their modes of action. Vaccine 15, 248-256, 1997.

De Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P., van Hoof, F., Lysosomotro- pic agents. Biochem. Pharmacol. 223, 2495-2531, 1974.

Denis-Mize, K.S., Dupuis, M., MacKichan, M.L., Singh, M., Doe, B., O´Hagan, D., Ul- mer, J.B., Donnelly, J.J., McDonald, D.M., Ott, G., Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen expression by dendritic cells. Gene Ther. 7(24), 2105-2112, 2000.

Dingler, A., Gohla, S., Production of solid lipid nanoparticles (SLN) scaling up feasibil- ities. J. Micorencapsul. 19(1), 11-16, 2002.

Domurado, M., Domurado, D., Vert, M., Stealth effect: Poly(ethylene glycol) is protein repulsive and albumin compatible. Proc. 4th World Meet. ADRITELF/APGI/APV, 831- 832, 2002.

Donnelly, J.J., New developments in adjuvants. Mech. of ageing and developm. 93, 171- 177, 1997.

Dupuis, M., Murphy, T.J., Higgins, D., Ugozzoli, M., Van Nest, G., Ott, G., McDonald, D.M., Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cellular Immunology 186 (1), 18-27, 1998.

Ellouz, F., Adam, A., Ciobaru, R., Lederer, E., Minimal structural requirements for adju- vant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59, 1317-1325, 1974.

Engvall, E., Perlmann, P., Enzyme-linked immunosorbent assay (ELISA). Quantitative as- say for immunoglobulin G. Immunochem. 8, 871-874, 1971.

Engvall, E., Perlmann, P., Enzyme linked immunosorbent assay (ELISA): III Quantifica- tion of specific antibodies by enzyme-linked anti-immunoglobulin in antigen coated tubes. J. Immunol. 109, 129, 1972.

Erbacher, P., Remy, J.-S., Behr, J.-P., Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6(1), 138-145, 1999.

Erodohazi, M., Newman, R.L., Aluminium hydroxide granuloma. Br. Med. J. 3, 621-623, 1971.

177 6 Literaturverzeichnis

Escriou, V., Ciolina, C., Lacroix, F., Byk, G., Scherman, D., Wils, P., Cationic lipid- mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipo- polyamine/DNA complexes. Biochim. Biophys. Acta 1368(2), 276-288, 1998a.

Escriou, V., Ciolina, C., Helbling-Leclerc, A., Wils, P., Scherman, D., Cationic lipid- mediated gene transfer: analysis of cellular uptake and nuclear import of plasmid DNA. Cell. Biol. Toxicol. 14(2), 95-104, 1998b.

Espinet, R.G., Nuevo tipo de vacuna antioftosa a compleja glucovirico. Gac. Vet. 74, 1-13, 1951.

Farhood, H., Serbina, N., Huang, L., The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235, 289-295, 1995.

Fasbender, A., Marshall, J., Moninger, T.O., Grunst, T., Cheng, S., Welsh, M.J., Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther. 4, 716-725, 1997.

Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L.L., Pepinsky, B., Barsoum, J., Tat- mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA, 91, 664- 668, 1994.

Felgner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M., Danielsen, M., Lipofection: a highly efficient, lipid-mediated DNA- transfection procedure. Proc. Natl. Acad. Sci. USA, 84, 7413-7417, 1987.

Felgner, P.L., Kumar, R., Basava, C., Border, R.C., Hwang-Felgner, J.-Y., Cationic lipids for intracellular delivery of biologically active molecules. US Patent No. 5,264,618, 1993.

Felgner, J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M., Felgner, P.L., Enhanced gene delivery and mechanism studies wiht a novel se- ries of cationic lipid formulations. J. Biol. Chem. 269, 2550-2561, 1994.

Fiedler, H.P., Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete. Editio Cantor Verlag Aulenhof, 4. Auflage, 1996.

Filion, M.C., Philips, N.C., Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids towards immune effector cells. Biochim. Biophys. Acta 1329, 345-356, 1997.

Filion, M.C., Philips, N.C., Major limitations in the use of cationic liposomes for DNA delivery. Int. J. Pharm. 162, 159-170, 1998.

Fok, A.K., Ueno, M.S., Azada, E.A., Allen, R.D., Phagosomal acidification in Parame- cium: effects on lysosomal fusion. Eur. J. Cell Biol. 43, 412, 1987.

Food Additive Database der FDA, Internet: www.fda.gov, 1999.

Fortin, A., Therien, H.-M., Mechanism of liposome adjuvanticity: An in vivo approach. Immunobiology 188, 316-322, 1993.

178 6 Literaturverzeichnis

Freitas, C., Lucks, J.S., Müller, R.H., Effect of storage conditions on long-term stability of Solid Lipid Nanoparticles (SLN) in aqueous dispersion. European Journal of Pharmaceuti- cal Sciences, 2/1, 178, 1994.

Freitas, C., Müller, R.H., Correlation between long-term stability of solid lipid nanoparti- cles (SLN) and crystallinity of the lipid phase. Europ. J. Pharm. Biopharm. 47, 125-132, 1999.

Freund, J., Casals, J., Hosmer, E.P., Sensitization and antibody formation after infection of tubercle bacilli and paraffin oil. Proc. Soc. Exp. Biol. Med. 37, 509-513, 1937.

Freund, J., The mode of action of immunological adjuvants. Adv. Tuberc. Res. 7, 130- 148, 1956.

Frost, L., Johansen, P., Pedersen, S., Veien, N., Ostergaard, P. A., Nielsen, M. H., Persis- tent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts. Allergy 40, 368-372, 1985.

Fundaro, A., Cavalli, R., Bargoni, A., Bihetto, D., Zara, G.P., Gasco, M.R., Non-stealth and stealth solid lipid nanoparticles (SLN) carrying Doxirubicin: Pharmacokinetics and tis- sue distribution after i. v. administration to rats. Pharmacol. Res. 42(4), 337-343, 2000.

Gao, X., Huang, L., A novel catioic liposome reagent for efficient transfection of mam- malian cells. Biophys. Res. Commun. 179, 280-285, 1991.

Gasco, M.R., Solid lipid nanospheres form warm micro-emulsions. Pharm. Tech. Eur. 12, 52-58, 1997.

George, A.J., Legal status and toxicity of saponins. Food Cosmet. Toxicol. 3, 85-91, 1965.

Glenny, A.T., Pope, C.G., Waddington, H., Wallace, V., The antigenic value of toxoid precipitated by potassium alum. J. Pathol. Bacteriol. 29, 38-45, 1926.

Gohla, S, Dingler, A., Scaling up feasibility of the production of solid lipid nanoparticles (SLN). Pharmazie 56, 61-63, 2001.

Gombotz, W.R., Wang, G.H., Horbett, T.A., Hoffman, A.S., Protein adsorbtion to poly(ethylen oxide) surfaces. J. Biomed. Mater. Res. 25(12), 1547-1562, 1991.

Gorlich, D., Kutay, U., Transport between the cell nucleus and the cytoplasm. Ann. rev. Cell Dev. Biol. 15, 607-660, 1999.

Grubhofer, N., An adjuvant formulation based on N-acetylglucosaminyl-N- acetylmuramyl-alanyl-D-isoglutamine with dimethyldioctadecylammonium chloride and zinc-L-proline complex as synergists. Immunol. Letters 44, 19-24, 1995.

Gupta, R.K., Relyveld, E.H., Flinkbald, E.B., Bizzini, B., Ben-Efraim, S., Gupta, C. K., Adjuvants – a balance between toxicity and adjuvanticity. Vaccine 11, 293-306, 1993.

Gupta, R.K., Rost, B.E., Relyveld, E., Siber, G.R., Adjuvant properties of aluminum and calcium compounds. In: Powell, M., Newman, J. (Ed.),Vaccine Design, Plenum Press, New York, 229-248, 1995.

179 6 Literaturverzeichnis

Gupta, R.K., Alroy, J., Alonso, M.J., Langer, R., Siber, G.R., Chronic local reactions, long term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microsheres composed of poly lactide-co-glycolide polymers. Vaccine 15, 1716-1723, 1997.

Gupta, R.K., Aluminum compounds as vaccine adjuvants. Adv. Drug Del. Rev. 32, 155- 172, 1998.

Gustafsson, J., Arvidson, G., Karlsson, G., Almgren, M., Complexes between cationic liposomes and DNA visualized by cryo TEM. Biochim. Biophys. Acta 1235(2), 305-312, 1995.

Hacein-Bey-Abina, Le Deist, S., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.P., Thrasher, A.J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., Fischer, A., Davies, E.G., Kuis, W., Leiva, L., Cavazzana-Calvo, M., Sustained Correction of x-Linked Severe Com- bined Immunodeficiency by ex vivo Gene Therapy. S., N. Engl. J. Med. 346(16), 1185- 1193, 2002.

Haensler, J., Szoska, F.C., Polyamidoamine cascade mediates efficiant transfection of cells in culture. Bioconjugate Chem. 4, 372-379, 1993.

Hafez, I.M., Maurer, N., Cullis, P.R., On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8, 1188-1196, 2001.

Heiati, H., Tawashi, H., Philips, N.C., Drug retention and stability of solid lipid nanoparti- cles containing azidothymidine palpitate after autoclaving, storage and lyophilization. J. Microencapsulation 15, 173-184, 1998.

Hilgers, L.A.T., Snippe, H. DDA as immunological adjuvant. Res. Immunol. 143, 494- 503, 1992.

Holmen, S.L., Vanbrocklin, M.W., Eversole, R.R., Stapleton, S.R., Ginsberg, L.C., Effi- cient lipid-mediated transfection of DNA into primary rat hepatocytes. In Vitro Cell Dev. Biol. Anim. 31(5), 347-351, 1995.

Hunt, K.K., Vorburger, S.A., Hurdles and Hopes for Cancer Treatment. Science 297, 415- 416, 2002.

Hunter, R.L., Bennett, B., The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblocks and octablock copolymers. J. Immunol. 133, 3167-3175, 1984.

Hunter, R.J., Foundations of Colloid Sciences, Vol. 1, Oxford University Press, Oxford, 1986.

Jahnke, S., The theory of high pressure homogenization, in: Müller, R.H., Benita, S., Bohm, B.(Hrsg.), Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Medpharm Scientific Publishers, Stuttgart, 177-200, 1998.

Jankovic, D., Caspar, P., Zweig, M., Adsorption to aluminum hydroxide promotes the ac- tivity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120. J. Immunol. 159, 2409-2317, 1997.

180 6 Literaturverzeichnis

Jans, D.A., Chan, C.K., Huebner, S., Signals mediating nuclear targeting and their regula- tion: application in drug elivery. Med. Res. Rev. 18, 189-223, 1998.

Jenning, V., Feste Lipidnanopartikel (SLN) als Trägersystem für die dermale Applikation von Retinol: Wirkstoffinkorporation, -freisetzung und Struktur. Dissertation FU Berlin, 1999.

Johnson, A.G., Gaines, S., Landy, M. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolyssaccharide. J. Exp. Med. 103, 225-246, 1956.

Journal of Gene Medicine, Gene Therapy Clinical Trails 2001, http://www.wiley.co.uk/genetherapy/clinical/.

Kahn, J.O., Clinical and immunologic responses to human immunodeficiency virus (HIV) type I SF2gpq120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoy phosphatidyl-ethanolamine in non GIV-infected human volunteers. J. Infect. Dis. 170, 1288-1291,1994.

Kawaura, C., Noguchi, A., Furuno, T., Nakanashi, M., Atomic force microscopy for studying gene transfection mediated by cationic liposomes with a cationic cholesterol de- rivative. FEBS Lett. 421, 69-72, 1998.

Keminer, O., Peters, R., Permeability of single nuclear pores. Biophys. J. 77, 217-218, 1999.

Kim, T.W., Chung, H., Kwon, I.C., Sung, H.C., Jeong, S.Y., Optimization of lipid compo- sition in cationic emulsions as in vitro and in vivo transfection agents. Pharm. Res. 18, 54- 60, 2001.

Kim, T.W., Kim, Y.J., Chung, H., Kwon, I.C., Sung, H.C., Jeong, S.Y., The role of non- ionic surfactants on cationic lipid mediated gene transfer. J. Contr. Rel. 82, 455-465, 2002.

Kneuer, C., New components for non-viral DNA delivery systems: surface modified silica nanoparticles and invasin A derived adhesion proteins. Dissertation, Universität des Saar- landes, 2000.

Kotin, R.M. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Human Gene Ther. 5, 793-801, 1994.

Kreuter, J., in Donbrow, M., Microcapsules and nanoparticles in medicine and pharmacy. Boca Raton, Fla.: CRC Press, 1992.

Labatmoleur, F., Steffan, A.M., Brisson, C., Perron, H., Feugeas, O., Furstenberger, P., Oberling, F., Brambilla, E., Behr, J.O., An electron-microscopy study into the mechanism of gene-transfer with lippolyamines. Gene Ther. 3, 1010-1017, 1996.

Lachman, L.B., Shih, L.-C., Rao, X.-M., Ullrich, S.E., Cleland, J., Cytokine-containing liposomes as adjuvants for subunit vaccines. In: Powell, M., Newman, J. (Ed.), Vaccine Design, Plenum Press, New York, 659-671, 1995.

181 6 Literaturverzeichnis

Lai, L.W., Moeckel, G.W., Lien, Y.H., Kidney-targeted liposome-mediated gene transfer in mice. Gene Ther. 4, 426-431, 1997.

Langenberg, A.G.M, A recombinant glycoprotein vaccine for herpes simplex type 2: safety and immunogenicity. Ann. Intern. Med. 122, 889-898, 1995.

Larsson, A., Balöw, R.M., Lindahl, T.L., Forsberg, P.O., Chicken antibodies: Taking ad- vantage of evolution – A review. Poultry Science 72, 1807-1812, 1993.

Leventis, R., Silvius, J.R. Interactions of mammalian cells with lipid dispersions contain- ing novel metabolizable cationic amphiphiles. Biochim. Biophys. Acta 1023, 124-132, 1990.

Lewin, M., Carlesso, N., Tung, C.H., Tang, X.W., Cory, D., Scadden, D.T., Weissleder,R., Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of pro- genitor cells. Nature Biotechnol. 18, 410-414, 2000.

Li, S., Huang, L., Nonviral gene therapy: promises and challenges. Gene Ther. 7, 31-34, 2000.

Liedtke, S., Zimmermann, E., Müller, R.H., Mäder, K., Physical characterization of solid lipid nanoparticles (SLN). Proc. Intern. Symp. Contr. Rel. Bioact. Mater. 26, 599-600, 1999.

Lindbald, E.B., Elhay, M.J., Silva, R., Appelberg, R., Andersen, O., Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect. Immun. 65, 623-629, 1997.

Liu, F., Yang, J., Huang, L., Liu, D., New cationic lipid formulations for gene transfer. Pharm. Res. 13, 1856-1860, 1996.

Liu, D., Qi, H., Huang, L., Liu, D., Factors controlling the efficiency of cationic lipid- mediated transfectionnnn in vivo via intravenous administration. Gene Ther. 4, 517-523, 1997.

Lösch, U, Schranner, I., Wanke, R., Jürgens, L., The chicken egg, an antibody source. J. Vet. Med. 33, 609-619, 1986.

Ludtke, J.J., Zhang, G.F., Sebestyen, M.G., Wolff, J.A., A nuclear licalization signal can enhance both the nuclear transport and expression of 1 kb DNA. J. Cell Sci. 112, 2033- 2041, 1999.

Luis, C., Afonso, C. Scharton, T.M., The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237, 1994.

Luthman, H., Magusson, G., High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic. Acids Res. 11, 1295-1308, 1983.

Maaßen, S., Schwarz, C., Mehnert, W., Lucks, J.S., Yunis-Specht, F., Müller, B.W., Mül- ler, R.H., Comparison of cytotxicity between polyester nanoparticles and solid lipid nano- particles (SLN). Proc. Int Symp. Contr. Release Bioact. Mater. 20, 490-491, 1993.

182 6 Literaturverzeichnis

Mark, A., Bjorksten, B., Granstrom, M., Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines. Vaccine 13, 669-673, 1995.

Marshall, E., Gene therapy death prompts review of adenovirus vector. Science 286, 2244-2245, 2000.

Martinez, I., Dornburg, R., Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes. Hum. Gene Ther. 7(6), 705-712, 1996.

Mc Kimm-Breschkin, J.L., The use fo TMB in solid phase immunoassays. J. Immunol. Mehtods 135, 277-280, 1990.

Mehnert, W., Mäder, K., Solid lipid nanoparticles Production, characterization and appli- cations. Adv. Drug Deliv. Rev. 47, 165-196, 2001.

Molina, M.C., Allison, S.D., Anchordoquy, T.J., Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: in sight from other structural indicators. J. Pharm. Sci. 90(10), 1445-1455, 2001.

Morein, B., Lövgren, K., Höglund, S., Sundquist, B., The ISCOM: an immunstimulating complex. Immunol. Today 8, 333-338, 1987.

Mosmann, T.R., Coffman, R.L., Th1 and Th2 cells: Different patterns of lymphokine se- cretion lead to different functional properties. Ann. Rev. Immunol. 7, 145-173, 1989.

Müller, B.W., Müller, R.H., Bestimmung von mittleren Durchmessern und Größenvertei- lungen im submikroskopischen Bereich mit der Photonenkorrelationsspektroskopie. Pharm. Ind. 45, 1150-1153, 1983.

Müller, B.W., Suppositorien, APV Monographie, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1986.

Müller, R.H., Mehnert, W., Lucks, J.-S., Schwarz, C., zur Mühlen, A., Weyhers, H., Frei- tas, C., Rühl, D., Solid lipid nanoparticles (SLN) – An alternative colloidal carrier system for controlled drug delivery. Eur. J. Biopharm. 41, 62-69, 1995.

Müller, R.H., Lucks, J.-S., Arzneistollträger aus festen Lipidteilchen - feste Lipid Nanos- hären (SLN), European Patent 0604597, 1996a.

Müller, R.H., Maaßen, S., Weyhers, H., Specht, F., Lucks, J.S., Cytotoxicity of magnetite loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles (SLN). Int. J. Pharm. 138, 85-94, 1996b.

Müller, R.H., Schuhmann, R., Teilchengrößenmessung in der Laborpraxis. APV Paper- back Band 28, Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, 1996c.

Müller, R.H., Zetapotential und Partikelladung in Laborpraxis. APV Paperback Band 37, Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, 1996d.

183 6 Literaturverzeichnis

Müller, R.H., Feste Lipidnanopartikel (SLN). In: Müller, R.H., Hildebrand, G.E., (Hrsg.), Pharmazeutische Technologie: Moderne Arzneiformen. 2. erweiterte Auflage, Wissen- schaftliche Verlagsgesellschaft Stuttgart, 1998.

Müller, R.H., Mäder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161-177, 2000a.

Müller, R.H., Dingler, A., Schneppe, T., Gohla, S., Large scale production of solid lipid nanoparticles (SLN) and nanosuspensions (DissoCubes). In: Wise, D. (Ed.), Handbook of Pharmaceutical Controlled Release Technology, Marcel Dekker Inc, New York, 2000b.

Müller, R.H., Grubhofer, N., Olbrich, C., Stabilitäts- und Biokompatibilitäts-optimiertes Adjuvans (SBA) zur Erhöhung der humoralen und zellulären Immunantwort. Deutsche Patentanmeldung Nr. 199 23 256.3 (M 4800), (13a) PCT-application PCT/EP00/04565 (P 55350), WO0071154 A2, 2000c.

Müller, R.H., Kneuer, C., Olbrich, C., Lehr, R.H., Transfektionskomplexe (TransoPlex®) mit reduzierter Toxizität, hoher physikalischer Stabilität und hoher Transfektionseffizienz. Deutsche Patentanmeldung Nr. 100 65 217.4, (P 56101), PCT/EP01/15287, 2001.

Murray, R., Cohen, P, Hardegree, M.C., Mineral oil adjuvants: biological and chemical studies. Ann. Aller. 30, 146-151, 1972.

Nagel, J., Svec, D., Water, T., Fireman, P., IgE synthesis in man I. Development of spe- cific IgE antibodies after immunization with tetanus-diphtheria (TD) toxoids. J. Immunol. 118, 334-341, 1977.

Nahde, T., Müller, K., Fahr, A., Müller, R., Brüsselbach, S., Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles. J. Gene Med. 3, 353-361, 2001.

Niven, R., Pearlman, R., Wedeking, R., Biodistribution of radiolabeled lipid-DNA com- plexes and DNA in mice. J. Pharm. Sci. 87, 1292-1299, 1998.

Nunberg, J., Doyle, M.V., York, S.M., York, C.J., Interleukin 2 acts as an adjuvant to en- hance the potency of inactivated rabies vaccine. Proc. Natl. Acad. Sci. USA 86, 4240- 4243, 1989.

O´Hagan, D.T., Ott, G.S., Van Nest, G., Recent advances in vaccine akjuvants: the devel- opment of MF59 emulsion and polymeric microparticles. Molec. Med. Today (2),69-75, 1997.

Odean, M.J., Frane, C.M., Van der Vieren, M., Tomai, M.A., Johnson, A.G., Involvement of gamma interferon in antibody enhancement by adjuvants. Infect. Immun. 58, 427-432, 1990.

Odelram, H., Granstrom, M., Hedenskog, S., Duchen, K., Bjorksten, B., Immunoglobulin E and G responses to pertussis toxin after booster immunization in atopy, local reactions and aluminium content of the vaccines. Pediatr. Allergy Immunol. 5, 118-123, 1994.

184 6 Literaturverzeichnis

Olbrich, C., Kayser, O., Müller, R.H., Grubhofer, N., Solid Lipid Nanoparticles (SLN) as vaccine adjuvant - study in sheep with a Mycoplasma bovis antigen and stability testing. Proc. 27th Int. Symp. Contr. Rel. Bioact. Matr., 293-294, 2000.

Olbrich, C., Kayser, O., Müller, R.H., Stability and biocompatibility optimized vaccine adjuvant (SBA) - based on Solid Lipid Nanopartikel (SLN). Proc. 28th Int. Symp. Contr. Rel. Bioact. Mater., 2001a.

Olbrich, C., Bakowsky, U., Lehr, C.-M., Müller, R., Kneuer, C., Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J. Contr. Rel. 77, 345-355, 2001b.

Ott, G., Barchfeld, G.L., Van Nest, G., Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine 13, 1557-1562, 1995.

Ott, G., The adjuvant MF59: The 1998 perspective, clinical performance and mechanism of action. Res. Immunol. 149, 25-27, 1998.

Ott, G., Singh, M., Kazzaz, J., Briones, M., Soenawan, E., Ugozzoli, M., O’Hagan, D.T., A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. J. Contr. Rel. 79, 1-5, 2002.

Ph. Eur. 1997 NT 2001, Sterilisationsmethoden und Sterilisationsbedingungen, Allgemei- ne Texte 5, 3. Ausgabe des Europäischen Arzneibuches, Nachtrag 2001, 380-382, 2001.

Philips, N.C., Gagné, L., Modulation of murine macrophages nitric oxide synthesis by liposomal phospholipids: correlation with liposome immune adjuvant activity. J. Drug. Target 3, 137-147, 1995.

Pietrobon, P.J.F., Liposome design and vaccine development. In: Powell, M., Newman, J.(Ed.), Vaccine Design, Plenum Press, New York, 347-361, 1995.

Pinnaduwage, P., Schmidt, L., Huang, L., Use of quarternary ammonium detergent in liposome mediated DNA transfektion of mouse L-cells. Biochim. Biophys. Acta. 985, 33- 37, 1989.

Plank, C., Zauner, W., Wagner, E., Applicaton of membrane-active peptides for drug and gene delivery across cellular membranes. Adv. Drug. Deliv. Rev. 34, 21-36, 1998.

Porteous, D.J., Dorin, J.R., McLachlan, G., Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 210-218, 1997.

Rädler, J.O., Koltover, I., Salditt, T., Safinya, C.R., Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275, 810-814, 1997.

Raff, S., Molekular Biologie der Zelle. Alberts, Bray, Lewis, Raff, Roberts, Watson (Hrsg.), VCH, 384-395, 1986.

185 6 Literaturverzeichnis

Ramon, G., Procedres pour acroitre la production des antitoxines. Ann. Inst. Pasteur 40, 1- 10, 1926.

Robbins, P.D., Tahara, H., Ghivizzani, S.C., Viral vectors for gene therapy. Trends in Biotech. 16, 35-40, 1998.

Roberts, W.R., Addy, M., Comparison of the in vivo and in vitro antibacterial properties of antiseptic mouthrinses containing chlorhexidine, alexidine, cetyl pyridinium chloride and hexetidine. Relevance to mode of action. J. Clin. Periodontol. 8, 295-310, 1981.

Rochlitz, C.F., Gene therapy of cancer. Swiss Medical Weekly 131(1-2); 4-9, 2001.

Rols, M.P., Delteil, C., Golzio, M., Dumond, P., Cros, S., Teissie, J., In vivo electrically mediated protein and gene transfer in murine melanoma. Nat. Biotechnol. 16, 168-171, 1998.

Rose, J.K., Buonocore, L., Witt, M.A., A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechniques 10(4), 520-525, 1991.

Ross, P.C., Hui, S.W., Lipoplex size is the major determinant of in vitro lipofection effi- ciency. Gene Ther. 6, 651-659, 1999.

Rote Liste® Arzneimittelverzeichnis für Deutschland, Rote Liste Service GmbH (Hrsg.), Frankfurt/Main, Editio Cantor Verlag, Aulendorf, 2002.

Rudolph, C., Plank, C., Lausier, J., Schilllinger, U., Müller, R.H., Rosenecker, J., Oli- gomers of the arginine-rich motif of the HIV-1 TAT protein: a novel approach for nonviral gene delivery. angenommen beim J. Biol. Chem, 2002.

Sanchez-Pescador, L. Burke, R.L., Ott, G., Van Nest, G., The effect of adjuvants on the efficacy of a recombinant herpes simplex glycoprotein vaccine. J. Immunol. 141, 1720- 1727, 1988.

Schade, R., Bürger, W., Schönberg, T., Schniering, A., Schwarzkopf, C., Hlinak, A., Ko- bilke, H., Aviäre vitelline Antikörper (Dotterantikörper): Ergebnisse zur Beeinflussung der Legeleistung von Hühnern nach Immunisierung mit Antigenen unterschiedlicher Art und Herkunft sowie zur Leistungsfähigkeit aviärer vitelliner Antikörper im Vergleich zu mammären Antikörpern. ALTEX 11, 75-84, 1994.

Schade, R., Hlinak, A., Egg yolk antibodyies, state of the art and future prospects. ALTEX 13, 5-9, 1996.

Schätzlein, A.G., Uchegbu, I.F., Non viral vectors in cancer gene therapy: principles and progress. Anti-Cancer Drugs 12, 275-303, 2001a.

Schätzlein, A.G., Uchegbu, I.F., Non-viral vectors in gene delivery. New Drugs 1(1), 17- 23, 2001b.

Schmidt, P., Erhard, M., Wanke, R., Hofmann, A., Schmahl, W., Lokale Reaktionen bei Verwendung verschiedener Adjuvantien bei Legehennen. ALTEX 13, 30-34, 1996.

186 6 Literaturverzeichnis

Schöler, N., Hahn, H., Müller, R.H., Liesenfeld, O., Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int. J. Pharm. 231, 167-176, 2001a.

Schöler, N., Olbrich, C., Tabatt, K., Müller, R.H., Hahn, H., Liesenfeld, O., Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int. J. Pharm. 221, 57-67, 2001b.

Schuhmann, R., Physikalische Stabilität parenteraler Fettemulsionen – Entwicklung eines Untersuchungsschemas unter besonderem Aspekt analytischer Möglichkeiten. Dissertation FU-Berlin, 1995.

Schwartz, B., Ivanov, M.A., Pitard, B., Escriou, V., Rangara, R., Byk, G., Wils, P., Crou- zet, J., Scherman, D., Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo. Gene Ther. 6, 282-292, 1999.

Schwarz, C., Feste Lipidnanopartikel: Herstellung, Charakterisierung, Arzneistoffinkorpo- ration und –freisetzung, Sterilisation und Lyophilisation. Dissertationsschrift, Freie Uni- versität Berlin, 1995a.

Schwarz, C. Freitas, C., Mehnert, W., Müller, R.H., Sterilisation and physical stability of drug-free and etomidate-loaded solid lipid nanoparticles. Proc. 22nd Int. Symp. Control. Release Bioact. Mater., 766-767, 1995b.

Schwarz, C., Mehnert, W., Sterilization of drug-free and tetracaine-loaded solid lipid nanoparticles (SLN). Proc. 1st World Meeting on Pharm. Techn., Biopharm. and Pharm. Biotechn., Budapest, 485-486, 1995c.

Schwarz, C., Mehnert, W., Freeze-drying of drug-free and drug-loaded solid lipid nano- partikles (SLN). Int. J. Pharm. 157, 171-179, 1997.

Shirodkar, S., Hutchinson, R.L., Perry, D.L., White, J.L., Hem, S.L., Aluminum com- pounds used as adjuvants in vaccines. Pharm. Res. 7, 1282-1288, 1990.

Siekmann, B., Westensen, K., Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1, 123-126, 1992.

Siekmann, B., Westensen, K., Thermoanalysis of recrystallization process of melt- homogenized glyceride nanoparticles. Colloids and Surfaces B: Biointerfaces 3, 159-175, 1994.

Simoes, S., Slepushkin, V., Duzgunes, N., Pedroso de Lima, M.C., On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes. Biochim. Biophys. Acta 1515(1), 23-37, 2001.

Singh, M., Briones, M., Ott, G., O’Hagan, D., Cationic microparticles: A potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. USA 97 (2), 811-816, 2000.

Siomi, H., Dreyfuss, G., A nuclear localization domain in the hnRNP A1 protein. J. Cell. Biol. 129, 551-560, 1995.

187 6 Literaturverzeichnis

Song, Y.K., Lui, F., Lui, D., Enhanced gene espression in mouse lung by prolonging the retention time of intravenously infected plasmid DNA. Gene Ther. 5, 1531-1571, 1998.

Sorgi, F.L., Bhattacharya, S., Huang, L., Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. 4, 961-968, 1997.

Stamatatos, L., Leventis, R., Zuckermann, M.J., Silvius, J.R., Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes. Bio- chemistry 27, 3917-3925, 1988.

Sun, S., DNA as an adjuvant: capacity of insect DNA and synthetic oligodesoxynucleo- tides to augment T cell response to specific antigens. J. Exp. Med. 187, 1145-1150, 1998.

Tabatt, K., Olbrich, C., Müller, R.H., Cytotoxicity testing of Solid Lipid Nanoparticles on RAW 264.7 macrophages. Proc. 4th World Meeting on Pharm. Techn., Biopharm. and Pharm. Biotechn., Florence, 699-700, 2002.

Thanou, M., Florea, B.I., Geldorf, M., Junginger, H.E., Borchard, G., Quaternized chito- san oligomers as novel gene delivery vectors in epithelia cell lines. Biomaterials 23(1), 153-159, 2002.

Torchilin, V.P., Rammohan, R., Weissig, V., Levenchenko, T.S., TAT peptide on the sur- face of liposomes affords their efficient intracellular delivery even at low temperture and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA 98, 8786-8791, 2001.

Ulrich, J.T., Myers, K.R., Monophosphoryl lipid A as an adjuvant, past experiences and new directions. Pharm. Biotechnol. 6, 495-524, 1995.

Valensi, J.M., Carlson, J.R. Van Nest, G. Systemic cytokine profiles in BALB/c mice im- munized with trivalent influenza vaccine containing MF59 oil emulsion and other ad- vanced adjuvants. J. Immunol. 153, 4029-4039, 1994.

Van der Lubben, I.M., Verhoef, J.C., Borchard, G., Junginger, H.E., Chitosan for muco- sal vaccination. Adv. Drug Del. Rev. 52(2), 139-144, 2001.

Van Dyke, R.W., Acidification of lysosomes and endosomes. In: Lloyd, L.B., Manson, R.W. (Eds.), Biology of the lysosome. Plenum Press, New York, 331-360, 1996.

Van Rooijen, N., Liposomes as an in vivo tool to study and manipulate macrophage func- tion. 41st Forum in Immunology, Res. Immunol. 143, 177-256, 1992.

Verma, I.M., Somia, N., Gene therapy – promises, problems and prospects. Nature 389, 239-242, 1997.

Vogel, F.R., Improving vaccine performance with adjuvants. Clin. Infect. Diseases 30, 266-270, 2000.

Wagner, E., Zenke, M, Cotton, M., Beug, H., Birnstiel, M.L., Transferrin-polycation con- jugates as carriers for DNA uptake into cells. Proc. Nat. Acad. Sci. USA 87, 3410-3414, 1990.

188 6 Literaturverzeichnis

Wagner, E., Zatloukai, K., Cotten, M., Kirlappos, H., Mechtler, K., Cureil, D.T., Birnstiel, M.L., Coupling of adenovirus to transferrin-polylysin/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. 89, 6099-6103, 1992.

Wang, J.B. Mucosal antibodies to human cytomegalovirus glycoprotein b occur following both natural infection and immunization with human cytomegalovirus vaccines. J. Ionfect. Dis 174, 387-392, 1996.

Wattiaux, R., Laurent, N., Wattiaux-De Conninck, S., Jadot, M., Endosomes, lysosomes: their implication in gene transfer. Adv. Drug Del. 41, 201-208, 2000.

Westensen, K., Bunjes, H., Do nanoparticles prepared from solid lipids at roomtempera- ture always possess a solid matrix? Int. J. Pharm. 155, 129-131, 1995.

Weyhers, H. Ehlers, S. Mehnert, W. Hahn, H., Müller, R.H., Solid Lipid Nanoparticles- Determination of In Vivo Toxicity. Proc. 1st World Meeting APGI/APV 489-490, 1995.

White, R.G., Coons, A.H., Conolly, J. M., Studies on antibody production III - The alum granuloma. J. Exp. Med. 102, 73-82, 1955.

White, W.I., Cassatt, D.R., Madsen, J., Burke, S. J., Woods, R. M., Wassed, N. M., Alving, C.R., Koenig, S., Antibody and cytotoxic-T-lymphocyte responses to a single lipo- some-associated peptide antigen. Vaccine 13, 1111-1122, 1995.

Wolff, J.A., Malone, R.W., Williams, R., Chong, W., Acsadi, G., Jani, A., Felgner, P.L., Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468, 1990.

Woodard, L., Adjuvant activity of water-insoluble surfactants. Lab. Anim. Sci. 39, 222- 225, 1989.

Wu, G.Y., Wu, C.H., Rezeptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429-4432, 1987.

Yang, N.S., Burgholder, J., Roberts, B., Martinell, B., McCabe, D., In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568-9572, 1990.

Yang, Y., Li, Q., Ertl, H.C.J., Wilson, J.M., Cellular and Humora Immune Responses to Viral Antigens Create Barriers to Lung-Directed Gene Therapy with Recombinant Adeno- viruses. J.Virol. 69(4), 2004-2015, 1995.

Yang, J.P., Huang, L., Direct gene transfer to mouse melanoma by intratumor injection of free DNA. Gene Ther. 3, 542-548, 1996.

Yang, J.P., Huang, L. Overcoming the inhibitory effect of serum on lipofection by in- creasing the charge ratio of cationic liposome to DNA. Gene Therapy, 4, 950-960, 1997.

Yi, S.W., Yun, T.Y., Kim, T.W., Chung, Y.W., Choi, Y.W., Kwon, I.C., Lee, E.B., Jiong, S.Q., A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system. Pharm. Res. 17, 314-320, 2000.

189 7 Literaturverzeichnis

Youhong, X., Francis, C., Szoka, Jr., Mechanism of DNA Release form Cationic Lipo- sosme/DNA Complexes Used in Cell Transfection. Biochem. 35, 5616-5623, 1996.

Yu, W.H., Kashani-Sabet, M., Liggitt, D., Moore, D., Heath, T.D., Debs, R.J., Topical gene delivery to murine skin. J. Invest. Dermatol. 112, 370-375, 1999.

Zabner, J., Fasbender, A.J., Moninger, T., Poellinger, K.A., Welsh, M.J., Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270, 18997-19007, 1995.

Zelphati, O., Uyechi, L.S., Barron, L.G., Szoka, F.C., Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their inter- actions with cells. Biochim. Biophys. Acta – Lipids and Biomembranes 1390(2), 119-133, 1998.

Zhang, Y.P., Self-assembling DNA-lipid particles for gene transfer. Pharm. Res. 14, 190- 196, 1997.

Zhou, X., Huang, L., DNA transfection mediated by cationic liposomes containing novel metabolizable cationic amphiphiles. Biochim. Biophys. Acta 1189, 195-203, 1994.

Zur Mühlen, A., Feste Lipidnanopartikel mit prolongierter Wirkstoffliberation. Dissertati- on FU Berlin, 1996a.

Zur Mühlen, A., zur Mühlen, E., Niehus, H., Mehnert, W., Atomic force microscopy stu- dies of solid lipid nanoparticles. Pharm. Res. 13(9), 1411-1416, 1996b.

190